Stock Events

Stock Events

Contineum Therapeutics (CTNM) Q2 2025 Earnings

May 14Confirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.62

-0.53

-0.44

-0.35

Details

Expected EPS

-0.565

Actual EPS

-0.62

Surprise EPS

-0.06

Surprise Percent

-9.73%

Description

⁨Contineum Therapeutics⁩ (⁦CTNM⁩) has reported earnings of ⁦-0.62⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.